PNPLA3 and Insulin resistance: In conclusion, our findings demonstrate that genetic variants in PNPLA3 and TM6SF2 do not act as independent risk factors for liver fibrosis, but amplify the detrimental effects of metabolic dysfunction (especially insulin resistance) and alcohol consumption.